Exodus Point Capital Management, LP Forte Biosciences, Inc. Transaction History

Exodus Point Capital Management, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$31.5 - $42.5 $1.42 Million - $1.91 Million	-45,019 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$25.01 - $40.24 $380,126 - $611,607	15,199 Added 50.97%	45,019 $1.54 Million
Q4 2020 Feb 16, 2021	BUY	$28.66 - $46.79 $854,641 - $1.4 Million	29,820 New	29,820 $1.09 Million

175K

Ticker FBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,340,300
Market Cap $371M
Description
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.